De-Escalation of Bone-Modifying Agents in Patients With Bone Metastases: The Best of Times and the Worst of Times? The bone-modifying agents zoledronic acid, pamidronate, and denosumab have essential ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

Here we describe the initial results of allogeneic bone marrow transplantation in three children with osteogenesis imperfecta, a genetic disorder in which osteoblasts produce defective type I ...

Learn about acute myelogenous leukemia (AML), its sneaky symptoms, aggressive nature, and how bone marrow produces defective ...

Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not ...

Such is the message of the post’s newest community initiative — a bone marrow registration drive launched in partnership with the National Marrow Donor Program (NMDP) to help improve patient outcomes ...

8 In addition, a Phase 2 trial for subacute stroke reported that intravenous infusion of bone marrow–derived mononuclear cells was safe but had no effect on measures of neurological function. 9 A ...

This happens when the leukemia cells crowd out the normal blood-making cells in the bone marrow. As a result, people don't have enough normal red blood cells, white blood cells, and blood platelets.

I was covering the story of a little girl named Emma Routh who needed a bone marrow transplant. One Saturday morning, I went to a donation drive being held in her honor. That’s where I signed up ...

He was set to defend the title against Shavkat Rakhmonov this past December, but a bone infection took him out. Della Maddalena won with a 49-46 scorecard and a pair of 48-47s for a unanimous decision ...